| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 737225 | Null | 0.0430277102950697 | -0.064925156 |
| NSC 745062 | Null | 0.0430277102950697 | -0.4067053 |
| NSC 746687 | (2E)-3-(2-phenyl-1H-indol-3-yl)-2-(phenylsulfonyl)acrylonitrile | 0.0430277102950697 | -0.37049513 |
| NSC 746701 | N-(4-Chlorophenyl)-N-({[2-(4-chlorophenyl)ethyl]amino]carbonothioyl)benzamide | 0.0430277102950697 | -0.22403597 |
| NSC 747556 | 6-(4'-Hydroxy-2'-methylphenyl)-2-benzenesulfonamide-4,5-dihydropyridazine-3(2H)-one | 0.0430277102950697 | -0.35820793 |
| NSC 749117 | 3-(2-Hydroxy-4-methoxyphenyl)-5-(4-methoxyphenyl)-1-(4-sulfamylphenyl)-2-pyrazoline | 0.0430277102950697 | -0.22464821 |
| NSC 750743 | (E)-3-(6-(thiophen-2-yl)imidazo[2,1-b]thiazol-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one | 0.0430277102950697 | -0.28787145 |
| NSC 752331 | (Z)-6-(2-(pyridin-2-ylmethylene)hydrazinyl)-9H-purine-9-beta-D-riboside | 0.0430277102950697 | -0.09120321 |
| NSC 756134 | GSK1023156A | 0.0430277102950697 | -0.24844969 |
| NSC 756170 | GSK317315A | 0.0430277102950697 | -0.26536029 |